Synaptogenix Inc (SNPX)

[sstyles]

On the one hand the market cap looks absurd compared to other Alz plays but then you have to consider this is still Alz, which is extremely complex given the vast amount of failed Alz trials.

I thought Neurotrope's last trial had a good chance of success and look how that ended up.

Alz is a very complex illness as often pointed out by Dr. Dale Bredesen who authored the End of Alzheimer's. An important read for those trying to understand the complexity here. To truly ameliorate Alz you may need a combo therapy and perhaps this drug may be part of such therapy but we are trying to correct bad dieting, lack of exercise from someone over a lifetime, and inflammation in the body that has led to his/her Alz. One drug may not be the panacea for that.

I'm invested but will probably take some risk off the table if the stock appreciates closer to the trial readout. This is still biotech. There are various ways to play this from an investment standpoint. I'm hoping the anticipation of the readout leads to increased share price to take some chips off the table.